- Capecitabine in the treatment of anal squamous cell carcinoma2022 | First Faculty of Medicine
- Different expression of thymidinphosphorylase in bowel mucosa and in primary colorectal tumor. The rationale principle for selective activation of capecitabine.2005 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Different expression of thymidinphosphorylase in bowel mucosa and in primary colorectal tumor. The rationale principle for selective activation of capecitabine.2005 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Capecitabin e and oxaliplatin (XELOX) in adjuvant therapy of colorectal cancer. Results of the NO16968 (XELOXA) trial2010 | First Faculty of Medicine
- Účinek kapecitabinu v léčbě triple negativního karcinomu prsu2020 | First Faculty of Medicine
- High efficacy of the combination chemotherapy (CT) of oral vinorelbine (NVBO) and capecitabine (X) with trastuzumab (H) in HER2-positive metastatic breast cancer (MBC): updated analysis of the results of an international phase 2 trialPublication without faculty affiliation
- First-line trastuzumab (H), oral vinorelbine (NVBo) and capecitabine (X) combination therapy for HER2-positive metastatic breast cancer (MBC): efficacy and safety in a multinational phase 2 studyPublication without faculty affiliation
- Neoadjuvant treatment of rectal adenocarcinoma2013 | Publication without faculty affiliation
- Systemic treatment of metastatic gastric cancer2021 | Publication without faculty affiliation
- Combination of neoadjuvant chemoradiotherapy and epidermal growth factor receptor inhibitors in the treatment of rectal adenocarcinoma2014 | First Faculty of Medicine
- Influence of preoperative chemoradiotherapy on changes of epidermal growth factor receptor expression in patients treated by preoperative chemoradiotherapy for local advanced rectal carcinoma2014 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové